887475-43-6

Basic information

• Product Name: 2-(Boc-aMino)-4-Methylthiophene
• Synonyms: 2-(Boc-aMino)-4-Methylthiophene;tert-butyl N-(4-methylthiophen-2-yl)carbamate;tert-Butyl (4-methylthiophen-2-yl)carbamate;Carbamic acid, (4-methyl-2-thienyl)-, 1,1-dimethylethyl ester
• CAS NO: 887475-43-6
• Molecular Formula: C10H15NO2S
• Molecular Weight: 213.2966
• Mol File: 887475-43-6.mol

Chemical Properties

• Boiling Point: 254.6±28.0 °C(Predicted)
• Appearance: /
• Density: 1.157±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 13.63±0.70(Predicted)
• CAS DataBase Reference: 2-(Boc-aMino)-4-Methylthiophene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(Boc-aMino)-4-Methylthiophene(887475-43-6)
• EPA Substance Registry System: 2-(Boc-aMino)-4-Methylthiophene(887475-43-6)

Safety Data

• Hazardous Substances Data: 887475-43-6(Hazardous Substances Data)

Usage

General Description

2-(Boc-amino)-4-methylthiophene is a chemical compound with the molecular formula C13H19NO3S. It is a derivative of thiophene, a five-membered aromatic ring containing sulfur. The "Boc" in its name refers to the tert-butoxycarbonyl (Boc) protecting group attached to the amino group, which is commonly used in organic synthesis to protect reactive functional groups. 2-(Boc-aMino)-4-Methylthiophene is often used as a building block in the synthesis of pharmaceuticals and agrochemicals. It can also be used as a precursor in the preparation of various heterocyclic compounds. Its distinct chemical structure and reactivity make it a valuable tool in organic synthesis for the creation of complex molecules.

Upstream product

• 14282-78-1 4-methylthiophene-2-carboxylic acid 
• 75-65-0 tert-butyl alcohol 

Downstream Products

• 14770-82-2 4-methyl-2-amino-thiophene 

Relevant articles and documents

SELECTIVE KINASE INHIBITORS

Provided are pyrimidine compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibition Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.

Methods for inhibiting protein kinases

The present invention provides methods for inhibiting protein kinases selected from the group consisting of AKT, Checkpoint kinase, Aurora kinase, Pim-1 kinase, and tyrosine kinase using imidazo[1,2-a]pyrazine compounds and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with protein kinases using such compounds.

Imidazopyrazines as protein kinase inhibitors

In its many embodiments, the present invention provides a novel class of imidazopyrazine compounds as inhibitors of protein and/or checkpoint kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or checkpoint kinases using such compounds or pharmaceutical compositions.